These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


351 related items for PubMed ID: 12940073

  • 1. [Expression of P21 WAF1/CIP1 in human astrocytomas in correlating with P53, MDM2, and cellular proliferation index].
    Xu QZ, Liu F, Lu DH, Yu SZ, Yang H.
    Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2001 Aug; 23(4):341-5. PubMed ID: 12940073
    [Abstract] [Full Text] [Related]

  • 2. Expression of p21/waf1 in oral squamous cell carcinomas--correlation with p53 and mdm2 and cellular proliferation index.
    Ng IO, Lam KY, Ng M, Regezi JA.
    Oral Oncol; 1999 Jan; 35(1):63-9. PubMed ID: 10211312
    [Abstract] [Full Text] [Related]

  • 3. MDM2 and p53 expression in gliomas: a multivariate survival analysis including proliferation markers and epidermal growth factor receptor.
    Korkolopoulou P, Christodoulou P, Kouzelis K, Hadjiyannakis M, Priftis A, Stamoulis G, Seretis A, Thomas-Tsagli E.
    Br J Cancer; 1997 Jan; 75(9):1269-78. PubMed ID: 9155045
    [Abstract] [Full Text] [Related]

  • 4. Expression of retinoblastoma gene product and p21 (WAF1/Cip 1) protein in gliomas: correlations with proliferation markers, p53 expression and survival.
    Korkolopoulou P, Kouzelis K, Christodoulou P, Papanikolaou A, Thomas-Tsagli E.
    Acta Neuropathol; 1998 Jun; 95(6):617-24. PubMed ID: 9650754
    [Abstract] [Full Text] [Related]

  • 5. Could changes in the regulation of the PI3K/PKB/Akt signaling pathway and cell cycle be involved in astrocytic tumor pathogenesis and progression?
    Hlobilkova A, Ehrmann J, Sedlakova E, Krejci V, Knizetova P, Fiuraskova M, Kala M, Kalita O, Kolar Z.
    Neoplasma; 2007 Jun; 54(4):334-41. PubMed ID: 17822324
    [Abstract] [Full Text] [Related]

  • 6. Expression patterns of cyclins D1, E and cyclin-dependent kinase inhibitors p21(Waf1/Cip1) and p27(Kip1) in urothelial carcinoma: correlation with other cell-cycle-related proteins (Rb, p53, Ki-67 and PCNA) and clinicopathological features.
    Ioachim E, Michael M, Stavropoulos NE, Kitsiou E, Hastazeris K, Salmas M, Stefanaki S, Agnantis NJ.
    Urol Int; 2004 Jun; 73(1):65-73. PubMed ID: 15263796
    [Abstract] [Full Text] [Related]

  • 7. p53 protein expression in breast carcinomas. Comparative study with the wild type p53 induced proteins mdm2 and p21/waf1.
    Giannikaki E, Kouvidou C, Tzardi M, Stefanaki K, Koutsoubi K, Gregoriou M, Zois E, Kakolyris S, Mavroudi C, Delides G, Georgoulias V, Kanavaros P.
    Anticancer Res; 1997 Jun; 17(3C):2123-7. PubMed ID: 9216675
    [Abstract] [Full Text] [Related]

  • 8. p21(Waf1/Cip1) expression and the p53/MDM2 feedback loop in gastric carcinogenesis.
    Craanen ME, Blok P, Offerhaus GJ, Meijer GA, Dekker W, Kuipers EJ, Meuwissen SG.
    J Pathol; 1999 Dec; 189(4):481-6. PubMed ID: 10629547
    [Abstract] [Full Text] [Related]

  • 9. Prognostic value of the apoptotic index analysed jointly with selected cell cycle regulators and proliferation markers in non-small cell lung cancer.
    Dworakowska D, Jassem E, Jassem J, Karmoliński A, Lapiński M, Tomaszewski D, Rzyman W, Jaśkiewicz K, Sworczak K, Grossman AB.
    Lung Cancer; 2009 Oct; 66(1):127-33. PubMed ID: 19200616
    [Abstract] [Full Text] [Related]

  • 10. Molecular abnormalities of p53, MDM2, and H-ras in synovial sarcoma.
    Oda Y, Sakamoto A, Satio T, Kawauchi S, Iwamoto Y, Tsuneyoshi M.
    Mod Pathol; 2000 Sep; 13(9):994-1004. PubMed ID: 11007040
    [Abstract] [Full Text] [Related]

  • 11. P21/waf1 protein expression in nasopharyngeal carcinoma. Comparative study with PCNA, p53 and MDM-2 protein expression.
    Kouvidou C, Stefanaki K, Dai Y, Tzardi M, Koutsoubi K, Darivianaki K, Karidi E, Rontogianni D, Zois E, Kakolyris S, Georgoulias V, Delides G, Kanavaros P.
    Anticancer Res; 1997 Sep; 17(4A):2615-9. PubMed ID: 9252690
    [Abstract] [Full Text] [Related]

  • 12. Predictive value of p53, mdm-2, p21, and mib-1 for chemotherapy response in advanced breast cancer.
    Sjöström J, Blomqvist C, Heikkilä P, Boguslawski KV, Räisänen-Sokolowski A, Bengtsson NO, Mjaaland I, Malmström P, Ostenstadt B, Bergh J, Wist E, Valvere V, Saksela E.
    Clin Cancer Res; 2000 Aug; 6(8):3103-10. PubMed ID: 10955790
    [Abstract] [Full Text] [Related]

  • 13. Inactivation of the p53 pathway in prostate cancer: impact on tumor progression.
    Osman I, Drobnjak M, Fazzari M, Ferrara J, Scher HI, Cordon-Cardo C.
    Clin Cancer Res; 1999 Aug; 5(8):2082-8. PubMed ID: 10473090
    [Abstract] [Full Text] [Related]

  • 14. Predictive value of cell cycle markers p53, MDM2, p21, and Ki-67 in superficial bladder tumor recurrence.
    Pfister C, Moore L, Allard P, Larue H, Lacombe L, Têtu B, Meyer F, Fradet Y.
    Clin Cancer Res; 1999 Dec; 5(12):4079-84. PubMed ID: 10632343
    [Abstract] [Full Text] [Related]

  • 15. Alterations affecting the p53 control pathway in bilharzial-related bladder cancer.
    Osman I, Scher HI, Zhang ZF, Pellicer I, Hamza R, Eissa S, Khaled H, Cordon-Cardo C.
    Clin Cancer Res; 1997 Apr; 3(4):531-6. PubMed ID: 9815716
    [Abstract] [Full Text] [Related]

  • 16. The role of p53, MDM2 and c-erb B-2 oncoproteins, epidermal growth factor receptor and proliferation markers in the prognosis of urinary bladder cancer.
    Korkolopoulou P, Christodoulou P, Kapralos P, Exarchakos M, Bisbiroula A, Hadjiyannakis M, Georgountzos C, Thomas-Tsagli E.
    Pathol Res Pract; 1997 Apr; 193(11-12):767-75. PubMed ID: 9521509
    [Abstract] [Full Text] [Related]

  • 17. High expression of MDM2 protein and low rate of p21(WAF1/CIP1) expression in SCID mice Epstein Barr virus-induced lymphoproliferation.
    El Mansouri S, Martin A, Mercadier A, Capoulade C, Maréchal V, Wiels J, Feuillard J, Raphaël M.
    J Histochem Cytochem; 1999 Oct; 47(10):1315-22. PubMed ID: 10490460
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Immunohistochemical detection of p53, mdm2, waf1/p21, and Ki67 proteins in bone marrow biopsies in myelodysplastic syndroms, acute myelogenous leukaemias and chronic myeloproliferative disorders.
    Kanavaros P, Stefanaki K, Rontogianni D, Darivianaki K, Vlychou M, Papadaki E, Eliopoulos G, Bakiri M, Matsouka C, Kakolyris S, Georgoulias V.
    Clin Exp Pathol; 1999 Oct; 47(5):231-8. PubMed ID: 10598372
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 18.